Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Monthly Plans Supply ~5 weeks per vial Details An excellent option for patients who prefer a lower upfront cost or who wish to assess their response to a specific formulation before committing to a longer supply
As of April 22, 2026, it was removed from FDA Category 2, but the FDA's Pharmacy Compounding Advisory Committee will not consider it for the 503A bulks list until the July 23, 2026 meeting
Both remain classified as research compounds, and all published data comes from preclinical and animal studies rather than human clinical trials
Insert the needle into the AOD 9604 vial at an angle, directing the stream against the glass wall
US$ 22.36
US$ 24.72
US$ 24.15
US$ 27.09
